Determinants in the uptake of the human papillomavirus vaccine: a systematic review based on European studies

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Determinants in the uptake of the human papillomavirus vaccine : a systematic review based on European studies. / de Casadevante, Victoria Fernández ; Cuesta , Julita Gil; Cantarero Arevalo, Lourdes.

I: Frontiers in Oncology, Bind 5, 141, 24.06.2015, s. 1-13.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

de Casadevante, VF, Cuesta , JG & Cantarero Arevalo, L 2015, 'Determinants in the uptake of the human papillomavirus vaccine: a systematic review based on European studies', Frontiers in Oncology, bind 5, 141, s. 1-13. https://doi.org/10.3389/fonc.2015.00141

APA

de Casadevante, V. F., Cuesta , J. G., & Cantarero Arevalo, L. (2015). Determinants in the uptake of the human papillomavirus vaccine: a systematic review based on European studies. Frontiers in Oncology, 5, 1-13. [141]. https://doi.org/10.3389/fonc.2015.00141

Vancouver

de Casadevante VF, Cuesta JG, Cantarero Arevalo L. Determinants in the uptake of the human papillomavirus vaccine: a systematic review based on European studies. Frontiers in Oncology. 2015 jun 24;5:1-13. 141. https://doi.org/10.3389/fonc.2015.00141

Author

de Casadevante, Victoria Fernández ; Cuesta , Julita Gil ; Cantarero Arevalo, Lourdes. / Determinants in the uptake of the human papillomavirus vaccine : a systematic review based on European studies. I: Frontiers in Oncology. 2015 ; Bind 5. s. 1-13.

Bibtex

@article{d2d2ad2df21c425ba6cfd28605385457,
title = "Determinants in the uptake of the human papillomavirus vaccine: a systematic review based on European studies",
abstract = "Background: Cervical cancer is the fourth most common cancer affecting women worldwide. Since 2006, two human papillomavirus vaccines (HPVV) have been licensed to protect women against the virus that causes cervical cancer. However, worldwide coverage remains unequal. Studies from the USA found strong evidence for differences in HPVV uptake by ethnicity and healthcare coverage. As the profile of ethnic groups and the healthcare system in the USA differ from countries in Europe where HPVV is free in most of the countries, we conducted a systematic review in order to analyze the determinants of HPVV uptake in Europe.Methods: We performed a systematic Pubmed, Scopus, and Science Direct search to find articles published from HPVV availability in European countries until April 2014. No age restriction was applied. We included all studies assessing factors associated with HPVV uptake. Uptake refers to either initiation and/or completion of the three dose vaccination program.Results: Out of the 23 eligible studies, 14 were retrospective reviews of data, six were cross-sectional surveys, and three were prospective cohort studies. Higher HPVV uptake was associated with ethnic majority populations, higher socio-economic status, regular cervical screening participation by the mother, and having received previous childhood vaccinations.Conclusion: Since the vaccine is offered for free in most of the European countries, the findings suggest that ethno-cultural and educational factors play an important role when it comes to HPVV uptake. Girls who were undervaccinated had also a lower uptake of standard childhood vaccines and mothers who were less likely to attend cervical cancer screening. This may indicate that only few parents have specific concerns with HPVV, and that preventive health care should seek ways to target these vulnerable groups.",
author = "{de Casadevante}, {Victoria Fern{\'a}ndez} and Cuesta, {Julita Gil} and {Cantarero Arevalo}, Lourdes",
note = "DOI:10.3389/fonc.2015.00141",
year = "2015",
month = "6",
day = "24",
doi = "10.3389/fonc.2015.00141",
language = "English",
volume = "5",
pages = "1--13",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S.A.",

}

RIS

TY - JOUR

T1 - Determinants in the uptake of the human papillomavirus vaccine

T2 - Frontiers in Oncology

AU - de Casadevante, Victoria Fernández

AU - Cuesta , Julita Gil

AU - Cantarero Arevalo, Lourdes

N1 - DOI:10.3389/fonc.2015.00141

PY - 2015/6/24

Y1 - 2015/6/24

N2 - Background: Cervical cancer is the fourth most common cancer affecting women worldwide. Since 2006, two human papillomavirus vaccines (HPVV) have been licensed to protect women against the virus that causes cervical cancer. However, worldwide coverage remains unequal. Studies from the USA found strong evidence for differences in HPVV uptake by ethnicity and healthcare coverage. As the profile of ethnic groups and the healthcare system in the USA differ from countries in Europe where HPVV is free in most of the countries, we conducted a systematic review in order to analyze the determinants of HPVV uptake in Europe.Methods: We performed a systematic Pubmed, Scopus, and Science Direct search to find articles published from HPVV availability in European countries until April 2014. No age restriction was applied. We included all studies assessing factors associated with HPVV uptake. Uptake refers to either initiation and/or completion of the three dose vaccination program.Results: Out of the 23 eligible studies, 14 were retrospective reviews of data, six were cross-sectional surveys, and three were prospective cohort studies. Higher HPVV uptake was associated with ethnic majority populations, higher socio-economic status, regular cervical screening participation by the mother, and having received previous childhood vaccinations.Conclusion: Since the vaccine is offered for free in most of the European countries, the findings suggest that ethno-cultural and educational factors play an important role when it comes to HPVV uptake. Girls who were undervaccinated had also a lower uptake of standard childhood vaccines and mothers who were less likely to attend cervical cancer screening. This may indicate that only few parents have specific concerns with HPVV, and that preventive health care should seek ways to target these vulnerable groups.

AB - Background: Cervical cancer is the fourth most common cancer affecting women worldwide. Since 2006, two human papillomavirus vaccines (HPVV) have been licensed to protect women against the virus that causes cervical cancer. However, worldwide coverage remains unequal. Studies from the USA found strong evidence for differences in HPVV uptake by ethnicity and healthcare coverage. As the profile of ethnic groups and the healthcare system in the USA differ from countries in Europe where HPVV is free in most of the countries, we conducted a systematic review in order to analyze the determinants of HPVV uptake in Europe.Methods: We performed a systematic Pubmed, Scopus, and Science Direct search to find articles published from HPVV availability in European countries until April 2014. No age restriction was applied. We included all studies assessing factors associated with HPVV uptake. Uptake refers to either initiation and/or completion of the three dose vaccination program.Results: Out of the 23 eligible studies, 14 were retrospective reviews of data, six were cross-sectional surveys, and three were prospective cohort studies. Higher HPVV uptake was associated with ethnic majority populations, higher socio-economic status, regular cervical screening participation by the mother, and having received previous childhood vaccinations.Conclusion: Since the vaccine is offered for free in most of the European countries, the findings suggest that ethno-cultural and educational factors play an important role when it comes to HPVV uptake. Girls who were undervaccinated had also a lower uptake of standard childhood vaccines and mothers who were less likely to attend cervical cancer screening. This may indicate that only few parents have specific concerns with HPVV, and that preventive health care should seek ways to target these vulnerable groups.

U2 - 10.3389/fonc.2015.00141

DO - 10.3389/fonc.2015.00141

M3 - Review

VL - 5

SP - 1

EP - 13

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

M1 - 141

ER -

ID: 140717754